Oncolmmune Founder On Merck Acquiring Company To Ramp Up Coronavirus Drug

*CNBC Exclusive: CNBC Transcript: Oncolmmune Founder and CEO Dr. Yang Liu speaks with CNBC’s “Squawk Box” today, discussing Oncolmmune being [acquired](https://www.valuewalk.com/2019/12/top-10-ma-sites/) by Merck.*Q3 2020 hedge fund letters, conferences and moreOncolmmune founder on Merck acquiring the company to ramp up supply of Covid-19 drugMEG TIRRELL: So, Merck is acquiring a small privately held company called Oncolmmune for $425 million. And this company has a drug for COVID-19, that’s proven to be strikingly effective in helping people who are hospitalized with the disease and requir…

Read More

HEDGE accordingly